@misc{10481/85090,
year = {2023},
month = {5},
url = {https://hdl.handle.net/10481/85090},
abstract = {Several international agencies recommend the study of new routes and new facilities for producing radioisotopes with application to nuclear medicine. Lu-177 is a versatile radioisotope used for therapy and diagnosis (theranostics) of cancer with good success in neuroendocrine tumours that is being studied to be applied to a wider range of tumours. Lu-177 is produced in few nuclear reactors mainly by the neutron capture on Lu-176. However, it could be produced at high -intensity accelerator-based neutron facilities. The energy of the neutrons in accelerator-based neutron facilities is higher than in thermal reactors. Thus, experimental data on the Yb-176(n,(sic)) cross-section in the eV and keV region are mandatory to calculate accurately the production of Yb-177, which beta decays to 177Lu. At present, there are not experimental data available from thermal to 3 keV of the Yb-176(n,(sic)) cross-section. In addition, there is no data in the resolved resonance region (RRR). This contribution shows the first results of the Yb-176 capture measurement performed at the n_TOF facility at CERN.},
organization = {Instituto de Salud Carlos III
Spanish Government
	PID2020-117969RB-I00},
organization = {Junta de Andalucía
	P20-00665,
	
	B-FQM-15-6UGR20},
publisher = {EDP Sciences},
title = {First high resolution measurement of neutron capture resonances in 176Yb at the n_TOF CERN facility},
doi = {10.1051/epjconf/202328409001},
author = {García Infantes, Francisco and Praena Rodríguez, Antonio Javier and Amar Es-Sghir, Hamza and Porras Sánchez, José Ignacio and Torres Sánchez, Pablo and n_TOF Collaboration},
}